Kidney cancer is being detected earlier thanks to modern diagnostic techniques, meaning more patients receive treatment.
Kidney cancer, by the numbers
Kidney cancers are a range of diseases that affect the body’s ability to filter waste products in the blood. They often develop without symptoms, which means they are normally picked up in tests for other reasons. The disease is one of the ten most common forms of cancer in developed countries, for reasons that are not well understood.
Common forms
Renal cell carcinoma (RCC) is the most common form of kidney cancer and affects tubules inside the kidney that transfer waste products from the blood to the urine through the glomerulus. RCC has multiple subtypes, of which clear-cell carcinoma is the most common. The remaining 10% of cancers are transitional cell carcinomas, which form in cells lining the renal pelvis and ureter2.
Global kidney cancer rates
Kidney cancer is more common in some parts of the world than in others3. People from developed countries are more than four times as likely to develop RCC than people from developing nations. Generally, there is less geographical variation for transitional cell cancers.
Trigger warning
Smoking and obesity are the biggest risk factors for kidney cancer.
Smoking
The falling popularity of smoking in developed countries could help to lower kidney-cancer incidence in these regions4.
Obesity
Every five-point increase in body mass index (BMI) increases risk by 24% for men and 34% for women. The rising level of obesity worldwide is likely to have contributed to increases in kidney cancer4.
Hypertension
Risk of kidney cancer increases with rising blood pressure. Although obesity can increase blood pressure, the two risk factors are independent and the chance of developing the disease is higher among individuals with both conditions than for those who have one4.
Developing story
Loss-of-function mutations in the gene VHL are responsible for about 60% of clear-cell carcinomas2. Around 2–3% of renal cell carcinomas run in families5. People with an inherited form of kidney cancer caused by von Hippel–Lindau syndrome (VHL) are born with a defect to an allele of VHL, and go on to acquire mutations that silence the gene. Most people with kidney cancer acquire VHL mutations during their lives as a result of environmental factors. A lack of symptoms can mean that some cancers can spread to other parts of the body before they are caught.
Mutations lead to blood-vessel formation
The VHL protein is a tumour suppressor, but this protein is missing in mutated cells. When this happens, the transcription factor HIF-α accumulates in cancer cells, leading to the overexpression of proteins (such as VEGF and TGF-α) that are normally only produced in low-oxygen environments.
Sources
1. Znaor, A. et al. Eur. Urol. 67, 519–530 (2015). 2. Cohen, H. T. et al. N. Engl. J. Med. 353, 2477–2490 (2005). 3. Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. (IARC, 2012). 4. Chow, W.-H. et al. Nature Rev. Urol. 7, 245–257 (2010). 5. Rini, B. I. et al. Lancet 373, 1119–1132 (2009).
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Shaw, G. The silent disease. Nature 537, S98–S99 (2016). https://doi.org/10.1038/537S98a
Published:
Issue Date:
DOI: https://doi.org/10.1038/537S98a
This article is cited by
-
Hypomethylation-Mediated Upregulation of NFE2L3 Promotes Malignant Phenotypes of Clear Cell Renal Cell Carcinoma Cells
Molecular Biotechnology (2024)
-
Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
Journal of Nanobiotechnology (2023)
-
Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer
Scientific Reports (2020)
-
Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
BMC Cancer (2019)
-
Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability
Oncogenesis (2019)